Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2009 08:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies, Inc. Raises $20.0 Million in a Common Stock Offering

NEW YORK, Dec. 10, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today...
November 09, 2009 16:00 ET | Source: SIGA Technologies Inc.

SIGA Technologies Reports Operating Results for the Third Quarter of 2009

NEW YORK, Nov. 9, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced its...
November 05, 2009 10:00 ET | Source: SIGA Technologies Inc.

SIGA Presents Update on ST-246(R) Development to the World Health Organization

NEW YORK, Nov. 5, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, today announced...
November 02, 2009 16:05 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Discuss Third Quarter 2009 Results of Operations on November 9, 2009

NEW YORK, Nov. 2, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, plans to announce...
October 30, 2009 08:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies Files $100 Million Shelf Registration

NEW YORK, Oct. 30, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced the...
September 29, 2009 08:30 ET | Source: SIGA Technologies Inc.

$1.6 Million NIH Cooperative Agreement Supports SIGA Broad Spectrum Antiviral Research

NEW YORK, Sept. 29, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced...
September 15, 2009 08:30 ET | Source: SIGA Technologies Inc.

ST-246 Used to Treat Complications From Exposure to Recombinant Vaccinia Virus

NEW YORK, Sept. 15, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies Inc. (Nasdaq:SIGA) announced that its smallpox antiviral drug, ST-246(R), has been used to treat a Pennsylvania patient suffering from...
September 03, 2009 08:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies Inc. Approved for NASDAQ Global Market Listing

NEW YORK, Sept. 3, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies Inc. (Nasdaq:SIGA) announced today that its common stock listing will transfer from the NASDAQ Capital Market to the NASDAQ Global Market....
September 02, 2009 09:00 ET | Source: SIGA Technologies Inc.

SIGA Technologies Receives a $3 Million Research Grant From the National Institutes of Health

NEW YORK, Sept. 2, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, today announced...
August 06, 2009 08:00 ET | Source: SIGA Technologies Inc.

SIGA Technologies Reports Operating Results for the Second Quarter of 2009

NEW YORK, Aug. 6, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced its...